Science 37
The Science 37 Metasite: The Power of 20 Sites in One.
Science 37
The Science 37 Metasite: The Power of 20 Sites in One.
Study enrollment rates have declined by more than 50% from pre-pandemic levels. To meet today’s challenges, the Science 37 Metasite expands your access to untapped patient populations and liberates you from geography and diversity limitations. With the power of virtual trial conduct, you’ll accelerate study recruitment and enrollment, while delivering high-quality data.
Study enrollment rates have declined by more than 50% from pre-pandemic levels. To meet today’s challenges, the Science 37 Metasite expands your access to untapped patient populations and liberates you from geography and diversity limitations. With the power of virtual trial conduct, you’ll accelerate study recruitment and enrollment, while delivering high-quality data.
Expanded Access to Patients Accelerates and Enhances your Clinical Trial.
There’s no substitute for speed. Compared to traditional site-based studies, the Science 37 Metasite accelerates your study’s recruitment and start up, while enabling greater patient retention and inclusivity.
Trials Without Science 37
Limited Participation: Only 8% of patients participate in traditional clinical research.
Slower Execution: Average start-up time is 31.4 weeks, with 80% delayed from enrollment.
Poor Retention: On average, trials have a 70% retention rate.
Limited Diversity: Only an average of 14% non-white representation.
Trials With the
Science 37 Metasite
Why Choose a Metasite?
A Metasite exists alongside traditional sites, improving patient experience- enabling faster trials.


Faster
Patient Recruitment.
Use a data-driven, omnichannel approach that makes it easier to recruit and enroll patients.


Accelerated Start-Up Times.
Meet clinical trial deadlines without sacrificing quality.


Better
Patient Experience.
The platform, people and processes designed to retain patients longer.


More Diversity.
Generate a more real-world representation with robust recruitment and expansive networks.

Recruitment Engine: Centralized Patient Engagement Ensures 100% Follow Up.
The Science 37 Metasite leverages real-world prevalence data to deliver data-driven feasibility assessments and uses an omni-channel recruitment approach to select the best channel for reaching receptive patients. Interactive screeners and a Centralized Patient Engagement Center drive high-efficiency enrollment so that no patient is lost to follow up.

Recruitment Engine: Centralized Patient Engagement Ensures 100% Follow Up.
The Science 37 Metasite leverages real-world prevalence data to deliver data-driven feasibility assessments and uses an omni-channel recruitment approach to select the best channel for reaching receptive patients. Interactive screeners and a Centralized Patient Engagement Center drive high-efficiency enrollment so that no patient is lost to follow up.
Eliminate the Need for Data Re-Entry.
The moment a study facilitator enters data and hits “submit”, the data is captured in the system and reflected in the patient journey without the need for manual re-entry.
Eliminate the Need for Data Re-Entry.
The moment a study facilitator enters data and hits “submit”, the data is captured in the system and reflected in the patient journey without the need for manual re-entry.
Proof the Science 37 Metasite™
Is Working on Every Level.
Sponsors and CROs who partner with Science 37 get access to the full range of Metasite capabilities at scale.
150+
Trials Launched
3x
More Diversity than Traditional Sites
33M+
Patients Accesible
34k+
Physician Providers
(contracted for research)